An improved method for the expression and purification of porcine dihydropyrimidine dehydrogenase.

作者: Brett A. Beaupre , Joseph V. Roman , Graham R. Moran

DOI: 10.1016/J.PEP.2020.105610

关键词:

摘要: Abstract Dihydropyrimidine dehydrogenase (DPD) catalyzes the reduction of uracil and thymine bases with electrons derived from NADPH. The mammalian DPD enzyme is a functional homodimer has an elaborate cofactor arrangement. Two flavin cofactors (FAD FMN) reside in two active site cavities that are separated by around 60 A. flavins apparently bridged four Fe4S4 clusters, which provided partner protomer dimer. study been hampered modest yield both native sources heterologous expression E. coli. In addition, minimal obtained when gene fused to N-terminal 6His-tag. This limitation dictated use traditional purification methods made more challenging apparent over-expression truncated and/or non-active forms DPD. Here we detail result ~4-fold improvement porcine expressed coli BL21 DE3 cells via pET plasmid system. addition ferrous ions sulfate during induction provide small increase purified enzyme. However, FAD FMN cell lysis results substantial activity also reduces relative proportion non-active, high molecular weight protein contaminants. We describe permit correlation content amount thus simple, rapid quantitation evaluation sample.

参考文章(36)
Robert B. Diasio, Glen D. Heggie, Jean-Pierre Sommadossi, David S. Cross, William J. Huster, Clinical Pharmacokinetics of 5-Fluorouracil and Its Metabolites in Plasma, Urine, and Bile Cancer Research. ,vol. 47, pp. 2203- 2206 ,(1987)
D.J. Porter, Dehalogenating and NADPH-modifying activities of dihydropyrimidine dehydrogenase. Journal of Biological Chemistry. ,vol. 269, pp. 24177- 24182 ,(1994) , 10.1016/S0021-9258(19)51065-1
D.J. Porter, W.G. Chestnut, B.M. Merrill, T Spector, Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil. Journal of Biological Chemistry. ,vol. 267, pp. 5236- 5242 ,(1992) , 10.1016/S0021-9258(18)42757-3
Ben Tallon, Nicholas Turnbull, 5% Fluorouracil Chemowraps in the Management of Widespread Lower Leg Solar Keratoses and Squamous Cell Carcinoma Australasian Journal of Dermatology. ,vol. 54, pp. 313- 316 ,(2013) , 10.1111/AJD.12055
Z.H. Lu, R Zhang, R.B. Diasio, Purification and characterization of dihydropyrimidine dehydrogenase from human liver Journal of Biological Chemistry. ,vol. 267, pp. 17102- 17109 ,(1992) , 10.1016/S0021-9258(18)41899-6
D.J. Porter, T Spector, Dihydropyrimidine dehydrogenase : kinetic mechanism for reduction of uracil by NADPH Journal of Biological Chemistry. ,vol. 268, pp. 19321- 19327 ,(1993) , 10.1016/S0021-9258(19)36516-0
Robert B. Diasio, Martin R. Johnson, Dihydropyrimidine Dehydrogenase: Its Role in 5-Fluorouracil Clinical Toxicity and Tumor Resistance Clinical Cancer Research. ,vol. 5, pp. 2672- 2673 ,(1999)
W. R. Hagen, M. A. Vanoni, K. Rosenbaum, K. D. Schnackerz, On the iron-sulfur clusters in the complex redox enzyme dihydropyrimidine dehydrogenase. FEBS Journal. ,vol. 267, pp. 3640- 3646 ,(2000) , 10.1046/J.1432-1327.2000.01393.X
R T Reilly, R B Dunlap, K W Barbour, F G Berger, Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase. Molecular Pharmacology. ,vol. 48, pp. 72- 79 ,(1995)
T. Skovsgaard, N.G.P. Davidson, M.J. Piccart, D.J. Richel, J. Bonneterre, D.T. Cirkel, C.M. Barton, S. Knight, A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer Annals of Oncology. ,vol. 12, pp. 1255- 1257 ,(2001) , 10.1023/A:1012249630074